Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39,876 | -$11,085 | -$24,565 | -$15,651 |
| Dep. & Amort. | $3,071 | $1,935 | $2,205 | $2,114 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | -$102 | $408 | $351 |
| Change in WC | -$782 | -$858 | $2,467 | -$3,562 |
| Other Non-Cash | $8,638 | $2,406 | -$1,879 | $5,974 |
| Operating Cash Flow | -$28,950 | -$7,704 | -$21,364 | -$10,774 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,606 | -$1,524 | -$1,536 | -$1,865 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $367 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $109 | $2,133 | $69 |
| Investing Cash Flow | -$2,239 | -$1,415 | $597 | -$1,796 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $47,245 | $18,761 | $0 | -$26,742 |
| Stock Issued | $0 | $0 | $0 | $79,462 |
| Stock Repurch. | $0 | $0 | -$37,314 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$27,707 | -$987 | $57,561 | $37,926 |
| Financing Cash Flow | $19,538 | $17,774 | $20,247 | $11,184 |
| Forex Effect | $2,090 | $106 | -$87 | $63 |
| Net Chg. in Cash | -$9,561 | $21,676 | -$13,522 | -$1,323 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $27,119 | $0 | $13,522 | $14,845 |
| End Cash | $17,558 | $21,676 | $0 | $13,522 |
| Free Cash Flow | -$31,338 | -$9,228 | -$22,900 | -$12,639 |